Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Viral Hepatitis

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2893.2008.01038.xPMID 18673425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.

  2007cited by this paper
• Ribavirin enhances osteoclast formation through osteoblasts via up-regulation of TRANCE/RANKL

  2007cited by this paper
• Bone mineral density before and after OLT: Long‐term follow‐up and predictive factors

  2006cited by this paper
• Assessment of bone metabolism and mineral density in chronic viral hepatitis.

  2006cited by this paper
• Interferon-alpha improves bone resorption and osteopenia in patients with chronic hepatitis C.

  2006cited by this paper
• Interferon-α improves bone resorption and osteopenia in patients with chronic hepatitis C

  2006cited by this paper
• Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

  2005cited by this paper
• Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

  2005cited by this paper
• The Effect of Ribavirin on Bone Density in Patients with Chronic Hepatitis C Treated with Interferon-Ribavirin Therapy

  2005cited by this paper
• Interplay between interferon and other cytokine systems in bone metabolism

  2005cited by this paper
• Ribavirin, but Not Interferon α-2b, is Associated with Impaired Osteoblast Proliferation and Differentiation In Vitro

  2004cited by this paper
• Ist Leberfibrose reversibel? Effekt von pegyliertem Interferon und Ribavirin bei Patienten mit chronischer Hepatitis C

  2003cited by this paper
• Osteopenia and osteoporosis in patients with end‐stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problem

  2003cited by this paper
• Osteoporosis in liver diseases and after liver transplantation.

  2003cited by this paper
• Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease

  2003cited by this paper
• RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

  2002cited by this paper
• Lack of evidence for ribavirin‐induced bone loss

  2002cited by this paper
• Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes

  2001cited by this paper
• Hepatic osteodystrophy

  2001cited by this paper
• Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study.

  2001cited by this paper
• The Use of Biochemical Markers of Bone Turnover in Osteoporosis

  2000cited by this paper
• Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation

  2000cited by this paper
• Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C.

  2000cited by this paper
• Influence of the Vitamin D Receptor Gene Polymorphism on Bone Loss in Men after Liver Transplantation

  1999cited by this paper
• Interferon-α, unlike interferon-γ, does not cause bone loss in the rat

  1999cited by this paper
• Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the rat.

  1999cited by this paper
• Collagen‐Related Markers of Bone Turnover Reflect the Severity of Liver Fibrosis in Patients with Primary Biliary Cirrhosis

  1998cited by this paper
• Bone mineral density, serum insulin‐like growth factor I, and bone turnover markers in viral cirrhosis

  1998cited by this paper
• Osteodystrophy in patients with chronic hepatitis and liver cirrhosis

  1996cited by this paper

• Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines

  2025cites this paper
• Impact of HCV cure on systemic inflammation and bone density, quality, and turnover

  2025cites this paper
• Differential Impact of Interferon-Based and Direct-Acting Antiviral Therapies on Bone Metabolism in Chronic Hepatitis C: Insights from Transcriptomic and Clinical Analyses

  2025cites this paper
• Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy

  2025cites this paper
• Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response

  2022cites this paper
• Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C.

  2022cites this paper
• Impact of Liver Cirrhosis on Bone Metabolism

  2022cites this paper
• REDUCED BONE MINERAL DENSITY IN YOUNG, NON-CIRRHOTIC PATIENTS WITH CHRONIC VIRAL HEPATITIS

  2022cites this paper
• Trabecular bone score and 3D-DXA in young, antiretroviral treatment-naïve patients in Madrid

  2021cites this paper
• Musculoskeletal Manifestations and Bone Mineral Density in Chronic Hepatitis C Patients

  2021cites this paper
• Os et foie

  2021cites this paper
• Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients

  2020cites this paper
• Bone Health in Patients With Liver Diseases.

  2020cites this paper
• Effects of HCV Eradication on Bone mineral density in HIV/HCV Coinfected Patients.

  2020cites this paper
• بررسی رابطه اینترفرون آلفا با تراکم استخوان در بیماران مبتلا به هپاتیت C

  2020cites this paper
• Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development

  2019influential citation
• Bone Diseases in Patients with Chronic Liver Disease

  2019cites this paper
• Osteoporosis in chronic liver disease

  2018cites this paper
• Hepatitis C virus infection and risk of osteoporotic fracture: A systematic review and meta‐analysis

  2018cites this paper
• Étude observationnelle de l’évolution sur trois ans de la densité osseuse de 215 patients vivant avec le VIH, traités, avec ou sans Ténofovir, à distance de l’induction thérapeutique

  2017cites this paper
• 25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients

  2017cites this paper
• Función renal en los pacientes con hepatopatía por virus C: Influencia en el tratamiento

  2017cites this paper
• Bone-Specific Alkaline Phosphatase Flare in a Patient with Hepatitis C: Case Report and Review of Literature

  2017cites this paper
• Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection

  2017cites this paper
• Hepatic Osteodystrophy: A Global (Re)View of the Problem.

  2017influential citation
• Body Composition Changes in Patients with Chronic Hepatitis C.

  2016cites this paper
• Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients

  2016cites this paper
• Crucial Role of Vitamin D in the Musculoskeletal System

  2016cites this paper
• Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture

  2016cites this paper
• Mechanisms of non-AIDS complications of HIV disease: role of hepatitis C co-infection

  2015cites this paper
• Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.

  2015cites this paper
• Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic Hepatitis C viral infection

  2014cites this paper
• Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis

  2014cites this paper
• Osteoporosis in Chronic Hepatitis C

  2014cites this paper
• Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin

  2014cites this paper
• Association of Interferon-alpha and bone density in patients with hepatitis C

  2014cites this paper
• Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications.

  2014cites this paper
• Bone Mineral Density Measurements, Bone Markers and Serum Vitamin D Concentrations in Men with Chronic Non-Cirrhotic Untreated Hepatitis C

  2013cites this paper
• Os et foie

  2013cites this paper
• Characterization Of Hcv Genotype 3a Structural Proteins Core, E1, E2 And Development Of Pseudotype Particles (HCVCC) And Intergenotypic Chimera (HCVCC)

  2013cites this paper
• Bone alterations in hepatitis C virus infected patients.

  2013cites this paper
• Hepatitis C Co‐infection and Severity of Liver Disease as Risk Factors for Osteoporotic Fractures Among HIV‐Infected Patients

  2013cites this paper
• Osteodystrophy in chronic liver diseases

  2013cites this paper
• Serum Sclerostin in Hepatitis C Virus Infected Patients

  2013cites this paper
• 25‐hydroxyvitamin D3 suppresses hepatitis C virus production

  2012cites this paper
• Review article: the extra‐skeletal effects of vitamin D in chronic hepatitis C infection

  2012cites this paper
• Bone health in persons with haemophilia: a review

  2012cites this paper
• IFNβ impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation

  2012cites this paper
• Risk of hip fracture associated with hepatitis c virus infection and hepatitis C/human immunodeficiency virus coinfection

  2012cites this paper
• Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection.

  2012cites this paper
• Proton Pump Inhibitors Increase the Incidence of Bone Fractures in Hepatitis C Patients

  2012cites this paper
• Osteoporosis in patients with chronic liver disease: An unfamiliar late complication

  2011cites this paper
• Classical and Emerging Roles of Vitamin D in Hepatitis C Virus Infection

  2011cites this paper
• Osteodistrofi a Hepática

  2011cites this paper
• Lebererkrankungen und Osteoporose

  2011cites this paper
• The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice

  2011cites this paper
• Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.

  2011cites this paper
• Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C

  2010cites this paper
• Liver and bone.

  2010cites this paper